Key Details
Counterparty: Qness Pharmaceuticals (Proprietorship Concern)
Agreement Specifics
- Area of Agreement: Collaboration for manufacture, procurement, supply, branding, marketing and distribution of pharmaceutical and allied products
- Geographic Scope: Domestic (India)
- Equity Structure: No joint venture, equity participation, or share exchange involved
- Operational Scope: Parties will collaborate for manufacture and/or procurement of pharmaceutical products and undertake branding, supply and distribution activities according to respective agreements and mutually agreed commercial arrangements
Financial Terms
- Consideration: No upfront consideration has been paid or received by either party
- Payment Structure: Commercial consideration shall be determined based on individual purchase orders and mutually agreed commercial terms from time to time
Related Party Status
- The counterparty is not a related party of Vivanta Industries Limited
- Promoters, Promoter Group and Group Companies of Vivanta have no interest in these arrangements
- All transactions are proposed to be undertaken on an arm's length basis
Counterparty Information
Qness Pharmaceuticals is a proprietorship concern engaged in the business of pharmaceutical products.
Rationale and Expected Benefits
The agreements are expected to:
- Strengthen the Company's business collaboration in the pharmaceutical sector
- Expand its product portfolio
- Enhance market reach
- Create opportunities for business growth through contract manufacturing and supply arrangements
Additional Commitments
The Company committed to make appropriate disclosure to the Stock Exchange along with reasons in the event these arrangements are terminated or called off, in accordance with SEBI LODR Regulations.